Stock listing

Novocure Limited

Selected listing: 038 · DUS · EUR · DE

Novocure Limited (Dusseldorf:038), Health Technology. Latest release Oct 1, 2026: Novocure to Report Third Quarter 2026 Financial Results.

038:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:038
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Dusseldorf
Currency: EUR

About Novocure Limited

Novocure Limited (NVCR) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Novocure Limited

Novocure to Report Third Quarter 2026 Financial Results

September 30, 2026

Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer

September 30, 2026

Novocure to Report Third Quarter 2026 Financial Results

October 1, 2026

Novocure Reports Second Quarter 2026 Financial Results

July 23, 2026

Novocure to Report Second Quarter 2026 Financial Results

July 1, 2026

All Novocure Limited news →

Events

Replays

NovoCure Limited (NVCR) Q2 2026 Earnings Call
Thu, Jul 23, 2026 · 08:00 AM ET
Watch
NovoCure Limited (NVCR) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 08:00 AM ET
Watch
NovoCure Limited (NVCR) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:00 AM ET
Watch

Research Novocure Limited

Novocure Limited company profile

View the public company page for Novocure Limited on 6ix.

Novocure Limited news

Read company news and market updates connected to Novocure Limited.

Novocure Limited investor events

Find investor webinars, events, and replay context for Novocure Limited.